Company / Working Capital per Share
Cardiff Oncology, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.66
FY2025
5-year range
$0.66 / $3.79
FY2021-FY2025
Trend
-64.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.18 in FY2017 to $14.81 in FY2020.
Based on SEC 10-K filings.
0.66 in FY2025 with a 5-year CAGR of -46.4%.
Declined from $1.50 to $0.66 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -35.6%
- 5-Year CAGR
- -46.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 64.0% year-over-year.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | -64.0% |
| FY2024 | $1.83 | +21.9% |
| FY2023 | $1.50 | -39.2% |
| FY2022 | $2.47 | -35.0% |
| FY2021 | $3.79 | -74.4% |
| FY2020 | $14.81 | +763.3% |
| FY2019 | $1.72 | -87.2% |
| FY2018 | $13.37 | +7328.7% |
| FY2017 | $0.18 | -82.8% |
| FY2016 | $1.05 | -67.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026